Stay updated on Timing of Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Timing of Pembrolizumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedA new history entry for revision v3.5.5 dated 2026-05-29 was added, including Contacts/Locations and Study Status, and the previous entry for 2026-05-26 (Revision: v3.5.4) was removed.SummaryDifference0.0%

- Check10 days agoChange DetectedNew entries were added to the history under Study Status for 2026-05-26 and a related 2026-05-22 entry with the value 684, and an entry dated 2026-05-13 was removed.SummaryDifference0.0%

- Check17 days agoChange DetectedVersion 683 (Revision: v3.5.4) was posted on 2026-05-13, adding the Arms and Interventions and Study Status sections to the study record. This update surfaces the trial design elements and the current status within the record.SummaryDifference0.0%

- Check31 days agoChange DetectedVersion entries 681 and 682 were added, introducing Study Status and Contacts/Locations sections to the record history. This captures updates to the study's current status and contact/location details in the history timeline.SummaryDifference0.1%

- Check39 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.5.3, replacing the previous v3.5.2 entry. This records the latest version of the page in the history.SummaryDifference0.0%

- Check46 days agoChange DetectedThe displayed revision/version number updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Timing of Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.